Collegium Pharmaceutical Ownership 2024 | Who Owns Collegium Pharmaceutical Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

35.56%

Insider Ownership

1.38%

Retail Ownership

63.06%

Institutional Holders

107.00

Collegium Pharmaceutical Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.17.92%0.00%5,793,383-72,516-1.24%186,546,932Jun 30, 2024
PACER ADVISORS, INC.10.54%0.25%3,408,369821,54131.76%109,749,482Jun 30, 2024
EVENTIDE ASSET MANAGEMENT, LLC8.15%1.45%2,634,6566150.02%84,835,923Jun 30, 2024
VANGUARD GROUP INC7.33%0.00%2,370,94240,2141.73%76,344,332Jun 30, 2024
RUBRIC CAPITAL MANAGEMENT LP7.22%1.97%2,333,500499,47327.23%75,138,700Jun 30, 2024
INVESCO LTD.5.28%0.01%1,706,61074,9544.59%54,952,843Jun 30, 2024
PRINCIPAL FINANCIAL GROUP INC5.20%0.03%1,680,860128,0038.24%54,123,661,000Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC4.74%0.08%1,531,498113,3007.99%49,314,236Jun 30, 2024
STATE STREET CORP4.27%0.00%1,379,95360,8984.62%44,434,487,000Jun 30, 2024
FULLER & THALER ASSET MANAGEMENT, INC.3.69%0.16%1,191,373222,17422.92%38,362,211Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP3.21%0.01%1,039,02419,8761.95%33,457,257Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC2.38%0.00%770,11536,5674.98%24,802,774Jun 30, 2024
EMERALD ADVISERS, LLC2.01%0.88%650,173-19,339-2.89%20,935,571Jun 30, 2024
MASSACHUSETTS FINANCIAL SERVICES CO /MA/2.01%0.01%649,365-12,433-1.88%20,909,553Jun 30, 2024
MORGAN STANLEY1.95%0.00%631,082-205,862-24.60%20,320,841Jun 30, 2024
EMERALD MUTUAL FUND ADVISERS TRUST1.64%0.89%530,45619,2553.77%17,080,683Jun 30, 2024
VICTORY CAPITAL MANAGEMENT INC1.53%0.02%494,814-31,149-5.92%15,933,011Jun 30, 2024
LSV ASSET MANAGEMENT1.18%0.03%380,551--12,254,000Jun 30, 2024
MAN GROUP PLC1.17%0.03%377,425116,48944.64%12,153,085Jun 30, 2024
NORTHERN TRUST CORP1.14%0.00%369,551-14,488-3.77%11,899,542,000Jun 30, 2024

Collegium Pharmaceutical's largest institutional shareholder is BLACKROCK INC., holding 17.92% of the company's total share outstanding, currently valued at $186.55M. The top 10 institutional shareholders own together 74.34% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
QUANTEDGE CAPITAL PTE LTD0.90%3.39%291,400119,10069.12%9,383,080Jun 30, 2024
RUBRIC CAPITAL MANAGEMENT LP7.22%1.97%2,333,500499,47327.23%75,138,700Jun 30, 2024
TEJARA CAPITAL LTD0.39%1.46%124,700124,700100.00%4,015,340Jun 30, 2024
EVENTIDE ASSET MANAGEMENT, LLC8.15%1.45%2,634,6566150.02%84,835,923Jun 30, 2024
THIRD AVENUE MANAGEMENT LLC0.56%1.01%182,28174,16168.59%5,869,448Jun 30, 2024
EMERALD MUTUAL FUND ADVISERS TRUST1.64%0.89%530,45619,2553.77%17,080,683Jun 30, 2024
EMERALD ADVISERS, LLC2.01%0.88%650,173-19,339-2.89%20,935,571Jun 30, 2024
SUMMERHAVEN INVESTMENT MANAGEMENT, LLC0.11%0.74%34,7734521.32%1,119,691Jun 30, 2024
UNIPLAN INVESTMENT COUNSEL, INC.0.45%0.43%146,375-543-0.37%4,713,000Jun 30, 2024
VALUES FIRST ADVISORS, INC.0.05%0.33%16,9931,0576.63%547,169Jun 30, 2024
REDWOOD INVESTMENTS, LLC0.09%0.31%28,11422,220376.99%899,378Jun 30, 2024
HILLSDALE INVESTMENT MANAGEMENT INC.0.36%0.29%114,8003,3002.96%3,696,560Jun 30, 2024
PACER ADVISORS, INC.10.54%0.25%3,408,369821,54131.76%109,749,482Jun 30, 2024
ACORN FINANCIAL ADVISORY SERVICES INC /ADV0.10%0.19%30,942-8,338-21.23%996,332Jun 30, 2024
RHS FINANCIAL, LLC0.03%0.19%9,4289,428100.00%303,582Jun 30, 2024
GLOBEFLEX CAPITAL L P0.16%0.18%52,938-7,132-11.87%1,704,604Jun 30, 2024
FULLER & THALER ASSET MANAGEMENT, INC.3.69%0.16%1,191,373222,17422.92%38,362,211Jun 30, 2024
AVIDITY PARTNERS MANAGEMENT LP0.36%0.16%117,000-244,400-67.63%3,767,400Jun 30, 2024
GALLACHER CAPITAL MANAGEMENT LLC0.03%0.16%9,3383,58262.23%300,684Jun 30, 2024
THRIVE WEALTH MANAGEMENT, LLC0.07%0.15%23,97623,976100.00%772,027Jun 30, 2024

The largest Collegium Pharmaceutical shareholder by % of total assets is QUANTEDGE CAPITAL PTE LTD. The company owns 291.40K shares of Collegium Pharmaceutical (COLL), representing 3.39% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PACER ADVISORS, INC.10.54%0.25%3,408,369821,54131.76%109,749,482Jun 30, 2024
RUBRIC CAPITAL MANAGEMENT LP7.22%1.97%2,333,500499,47327.23%75,138,700Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.1.09%0.12%352,000311,292764.69%11,334,400Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.1.12%0.03%362,137291,286411.12%11,660,811Jun 30, 2024
FULLER & THALER ASSET MANAGEMENT, INC.3.69%0.16%1,191,373222,17422.92%38,362,211Jun 30, 2024
GOLDMAN SACHS GROUP INC1.07%0.00%345,524181,574110.75%11,125,873Jun 30, 2024
PRINCIPAL FINANCIAL GROUP INC5.20%0.03%1,680,860128,0038.24%54,123,661,000Jun 30, 2024
TEJARA CAPITAL LTD0.39%1.46%124,700124,700100.00%4,015,340Jun 30, 2024
FIRST TRUST ADVISORS LP0.38%0.00%122,971122,971100.00%3,959,666Jun 30, 2024
QUANTEDGE CAPITAL PTE LTD0.90%3.39%291,400119,10069.12%9,383,080Jun 30, 2024
MAN GROUP PLC1.17%0.03%377,425116,48944.64%12,153,085Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC4.74%0.08%1,531,498113,3007.99%49,314,236Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.94%0.00%303,870110,49957.14%9,784,614Jun 30, 2024
SEGALL BRYANT & HAMILL, LLC0.24%0.04%78,30778,307100.00%2,521,485Jun 30, 2024
INVESCO LTD.5.28%0.01%1,706,61074,9544.59%54,952,843Jun 30, 2024
THIRD AVENUE MANAGEMENT LLC0.56%1.01%182,28174,16168.59%5,869,448Jun 30, 2024
SQUAREPOINT OPS LLC0.34%0.01%110,33872,874194.52%3,552,884Jun 30, 2024
MARSHALL WACE, LLP0.22%0.00%70,96470,964100.00%2,285,040Jun 30, 2024
STATE STREET CORP4.27%0.00%1,379,95360,8984.62%44,434,487,000Jun 30, 2024
NOMURA HOLDINGS INC0.17%0.00%54,90454,904100.00%1,767,909Jun 30, 2024

As of Jun 30 2024, Collegium Pharmaceutical's largest institutional buyer is PACER ADVISORS, INC.. The company purchased 821.54K stocks of COLL, valued at $109.75M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CAMBER CAPITAL MANAGEMENT LP----852,900-100.00%-Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP----562,000-100.00%-Jun 30, 2024
JANUS HENDERSON GROUP PLC0.04%0.00%13,913-549,492-97.53%447,929Jun 30, 2024
PENN CAPITAL MANAGEMENT COMPANY, LLC----244,516-100.00%-Jun 30, 2024
ELEQUIN SECURITIES, LLC----244,516-100.00%-Jun 30, 2024
AVIDITY PARTNERS MANAGEMENT LP0.36%0.16%117,000-244,400-67.63%3,767,400Jun 30, 2024
MORGAN STANLEY1.95%0.00%631,082-205,862-24.60%20,320,841Jun 30, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.23%0.00%72,737-205,776-73.88%2,342,000Jun 30, 2024
NEW YORK STATE COMMON RETIREMENT FUND0.04%0.00%13,276-143,040-91.51%427,000Jun 30, 2024
SOUTH DAKOTA INVESTMENT COUNCIL0.10%0.02%32,916-124,856-79.14%1,060,000Jun 30, 2024
HRT FINANCIAL LP----98,586-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----92,992-100.00%-Jun 30, 2024
TREXQUANT INVESTMENT LP0.05%0.01%15,806-92,421-85.40%508,953Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----88,603-100.00%-Jun 30, 2024
EAM INVESTORS, LLC----79,949-100.00%-Jun 30, 2024
BLACKROCK INC.17.92%0.00%5,793,383-72,516-1.24%186,546,932Jun 30, 2024
LOOMIS SAYLES & CO L P0.62%0.01%201,309-70,643-25.98%6,482,000Jun 30, 2024
BANK OF AMERICA CORP /DE/0.40%0.00%130,825-67,673-34.09%4,212,565Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC0.60%0.01%195,526-57,220-22.64%6,295,937Jun 30, 2024
LPL FINANCIAL LLC0.21%0.00%66,709-43,077-39.24%2,148,030Jun 30, 2024

As of Jun 30 2024, Collegium Pharmaceutical's biggest institutional seller is CAMBER CAPITAL MANAGEMENT LP. The company sold -0.85M shares of COLL, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FIRST TRUST ADVISORS LP0.38%0.00%122,971122,971100.00%3,959,666Jun 30, 2024
SEGALL BRYANT & HAMILL, LLC0.24%0.04%78,30778,307100.00%2,521,485Jun 30, 2024
NOMURA HOLDINGS INC0.17%0.00%54,90454,904100.00%1,767,909Jun 30, 2024
CREDIT AGRICOLE S A0.13%0.01%42,70042,700100.00%1,374,940Jun 30, 2024
CAMPBELL & CO INVESTMENT ADVISER LLC0.13%0.11%41,70441,704100.00%1,342,869Jun 30, 2024
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V.0.10%0.00%31,41731,417100.00%1,011,628Jun 30, 2024
THRIVE WEALTH MANAGEMENT, LLC0.07%0.15%23,97623,976100.00%772,027Jun 30, 2024
CAPULA MANAGEMENT LTD0.07%0.01%22,45722,457100.00%723,115Jun 30, 2024
SHERBROOKE PARK ADVISERS LLC0.06%0.11%18,99018,990100.00%611,478Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.06%0.00%18,89718,897100.00%608,483Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.05%0.00%16,27016,270100.00%523,894Jun 30, 2024
TWINBEECH CAPITAL LP0.05%0.01%16,03916,039100.00%516,456Jun 30, 2024
FOUNDRY PARTNERS, LLC0.05%0.03%15,27215,272100.00%491,758Jun 30, 2024
BOKF, NA0.05%0.01%15,20815,208100.00%489,698Jun 30, 2024
CHOREO, LLC0.04%0.01%12,15012,150100.00%396,309Jun 30, 2024
VERITION FUND MANAGEMENT LLC0.03%0.00%10,39010,390100.00%334,558Jun 30, 2024
RHS FINANCIAL, LLC0.03%0.19%9,4289,428100.00%303,582Jun 30, 2024
OMERS ADMINISTRATION CORP0.02%0.00%7,9007,900100.00%254,380Jun 30, 2024
KESTRA PRIVATE WEALTH SERVICES, LLC0.02%0.00%7,0447,044100.00%226,817Jun 30, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD0.02%0.03%6,9476,947100.00%224,000Jun 30, 2024
AXA S.A.0.02%0.00%6,5016,501100.00%209,333Jun 30, 2024
AVANTAX ADVISORY SERVICES, INC.0.02%0.00%6,4136,413100.00%206,499Jun 30, 2024
RAFFERTY ASSET MANAGEMENT, LLC0.02%0.00%6,3066,306100.00%203,053Jun 30, 2024
AMUNDI0.02%0.00%4,8964,896100.00%158,435Jun 30, 2024
WEALTHCOLLAB, LLC0.00%0.00%207207100.00%6,666Jun 30, 2024
SRS CAPITAL ADVISORS, INC.0.00%0.00%155155100.00%4,991Jun 30, 2024
SMARTLEAF ASSET MANAGEMENT LLC0.00%0.00%7979100.00%2,562Jun 30, 2024
FIRST HORIZON ADVISORS, INC.0.00%-2626100.00%837Jun 30, 2024
HOLLENCREST CAPITAL MANAGEMENT0.00%-2525100.00%805Jun 30, 2024
PARALLEL ADVISORS, LLC--1212100.00%386Jun 30, 2024
LARSON FINANCIAL GROUP LLC--22100.00%64Jun 30, 2024

Collegium Pharmaceutical's largest new institutional shareholder by number of shares is FIRST TRUST ADVISORS LP, purchased 122.97K shares, valued at $3.96M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CAMBER CAPITAL MANAGEMENT LP----852,900-100.00%-Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP----562,000-100.00%-Jun 30, 2024
PENN CAPITAL MANAGEMENT COMPANY, LLC----244,516-100.00%-Jun 30, 2024
ELEQUIN SECURITIES, LLC----244,516-100.00%-Jun 30, 2024
HRT FINANCIAL LP----98,586-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----92,992-100.00%-Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----88,603-100.00%-Jun 30, 2024
EAM INVESTORS, LLC----79,949-100.00%-Jun 30, 2024
WINTON GROUP LTD----42,369-100.00%-Jun 30, 2024
CANADA PENSION PLAN INVESTMENT BOARD----37,566-100.00%-Jun 30, 2024
JACKSON CREEK INVESTMENT ADVISORS LLC----30,714-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----17,624-100.00%-Jun 30, 2024
JANNEY MONTGOMERY SCOTT LLC----13,370-100.00%-Jun 30, 2024
TEZA CAPITAL MANAGEMENT LLC----9,423-100.00%-Jun 30, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----8,930-100.00%-Jun 30, 2024
AQUATIC CAPITAL MANAGEMENT LLC----8,800-100.00%-Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.----8,573-100.00%-Jun 30, 2024
MERITAGE PORTFOLIO MANAGEMENT----8,141-100.00%-Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.----7,867-100.00%-Jun 30, 2024
PETRUS TRUST COMPANY, LTA----6,154-100.00%-Jun 30, 2024
INSTITUTE FOR WEALTH MANAGEMENT, LLC.----6,068-100.00%-Jun 30, 2024
EQIS CAPITAL MANAGEMENT, INC.----5,515-100.00%-Jun 30, 2024
AXS INVESTMENTS LLC----5,445-100.00%-Jun 30, 2024
FOX RUN MANAGEMENT, L.L.C.----5,401-100.00%-Jun 30, 2024
SHEAFF BROCK INVESTMENT ADVISORS, LLC----5,250-100.00%-Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC----5,153-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----1,847-100.00%-Jun 30, 2024
USA FINANCIAL PORTFORMULAS CORP----660-100.00%-Jun 30, 2024
TRUVESTMENTS CAPITAL LLC----358-100.00%-Jun 30, 2024
SACHETTA, LLC----24-100.00%-Jun 30, 2024
FINANCIAL GRAVITY ASSET MANAGEMENT, INC.----11-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----7-100.00%-Jun 30, 2024

Collegium Pharmaceutical's largest sold out institutional shareholder by shares sold is CAMBER CAPITAL MANAGEMENT LP, sold -0.85M shares, valued at -, as of undefined.

Collegium Pharmaceutical Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC1.26%1,000,000--Dec 29, 2023
Delaware Enhanced Global Dividend & Income Fund0.78%288,000--Feb 28, 2023
TETON WESTWOOD FUNDS0.77%500,000--Dec 29, 2023
BANCROFT FUND LTD0.72%1,000,000--Dec 29, 2023
ELLSWORTH GROWTH & INCOME FUND LTD0.71%1,000,000--Dec 29, 2023
DELAWARE GROUP EQUITY FUNDS IV0.58%678,000--Mar 28, 2024
DELAWARE INVESTMENTS DIVIDEND & INCOME FUND, INC0.57%150,000--Feb 28, 2023
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC0.50%400,000--Dec 29, 2023
HIGHLAND FUNDS II0.50%7,399--Dec 31, 2023
BANCROFT FUND LTD0.32%450,000--Dec 29, 2023
ELLSWORTH GROWTH & INCOME FUND LTD0.32%450,000--Dec 29, 2023
ROYCE CAPITAL FUND0.28%103,79332,16444.90%Mar 31, 2024
DSS AMERICAFIRST QUANTITATIVE FUNDS0.25%5,593--Dec 29, 2023
TETON WESTWOOD FUNDS0.15%100,000--Dec 29, 2023
VALUED ADVISERS TRUST0.13%122,744--Jan 31, 2024
Federated Hermes MDT Series0.13%316,301206,096187.01%Jan 31, 2024
Capitol Series Trust0.09%925,379925,379-Mar 31, 2024
BUFFALO FUNDS0.08%500,000--Mar 31, 2024
ROYCE VALUE TRUST, INC.0.06%45,96510,92731.19%Mar 31, 2024
Pacer Funds Trust0.05%2,545,8961,043,83469.49%Jan 31, 2024
STATE STREET INSTITUTIONAL FUNDS0.05%37,510--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.05%24,298--Mar 31, 2024
FRANKLIN STRATEGIC SERIES0.04%362,235--Jan 31, 2024
VANGUARD ADMIRAL FUNDS0.04%177,009-4,695-2.58%Feb 29, 2024
OBERWEIS FUNDS0.04%41,200--Mar 31, 2024
SYNTAX ETF TRUST0.03%937-435-31.71%Mar 31, 2024
BNY MELLON INDEX FUNDS, INC.0.03%32,736-7,694-19.03%Jan 31, 2024
HUSSMAN INVESTMENT TRUST0.03%102,000--Dec 31, 2023
BNY MELLON INVESTMENT PORTFOLIOS0.03%16,023-265-1.63%Mar 31, 2024
MFS SERIES TRUST I0.02%432,733--Feb 29, 2024
ROYCE FUND0.02%136,122106,113353.60%Mar 31, 2024
THIRD AVENUE TRUST0.02%108,120108,120-Jan 31, 2024
DELAWARE VIP TRUST0.02%68,000--Mar 28, 2024
HIGHLAND GLOBAL ALLOCATION FUND0.02%18,900--Dec 31, 2023
AIM GROWTH SERIES (INVESCO GROWTH SERIES)0.02%511,86754,82812.00%Mar 31, 2024
RBB Fund Trust0.02%15,634-5,011-24.27%Feb 29, 2024
EXCHANGE TRADED CONCEPTS TRUST0.01%76,939--Feb 29, 2024
LAZARD FUNDS INC0.01%535,000--Mar 31, 2024
Vericimetry Funds0.01%1,110-810-42.19%Mar 31, 2024
World Funds Trust0.01%141,2589,9087.54%Jan 31, 2024
Bernstein Fund Inc0.01%94,740-29,040-23.46%Mar 31, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.01%24,915--Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND0.01%92,793--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%57,301-6,119-9.65%Mar 31, 2024
DELAWARE GROUP EQUITY FUNDS V0.01%539,000--Feb 29, 2024
Humankind Benefit Corp0.01%199-15-7.01%Dec 31, 2023
Gabelli Healthcare & WellnessRx Trust0.01%1,000--Dec 29, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%4,758-593-11.08%Mar 31, 2024
VICTORY PORTFOLIOS0.01%233,408-126,867-35.21%Mar 31, 2024
UBS FUNDS0.01%31,875--Mar 31, 2024
DRIEHAUS MUTUAL FUNDS0.01%56,981--Mar 28, 2024
IndexIQ ETF Trust0.01%13,651-860-5.93%Jan 31, 2024
Nushares ETF Trust0.00%35,419--Jan 31, 2024
NEUBERGER BERMAN EQUITY FUNDS0.00%47,334--Feb 29, 2024
TETON WESTWOOD FUNDS0.00%3,000--Dec 29, 2023
Mutual of America Variable Insurance Portfolios, Inc.0.00%3,202-71-2.17%Sep 30, 2023
HARBOR FUNDS0.00%100,000--Jan 31, 2024
MFS VARIABLE INSURANCE TRUST0.00%129,6197260.56%Mar 31, 2024
Lattice Strategies Trust0.00%6,2991,53032.08%Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%341,853289,005546.86%Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%877--Mar 31, 2024
FORUM FUNDS II0.00%3,800--Jan 31, 2024
FINANCIAL INVESTORS TRUST0.00%290,978-4,000-1.36%Jan 31, 2024
VANGUARD INDEX FUNDS0.00%1,477,606-453,812-23.50%Mar 31, 2024
MASSMUTUAL PREMIER FUNDS0.00%97,440-9,228-8.65%Dec 31, 2023
JNL VARIABLE FUND LLC0.00%17,182--Mar 31, 2020
SCHWAB CAPITAL TRUST0.00%127,073-989-0.77%Jan 31, 2024
UNIFIED SERIES TRUST0.00%48,075--Mar 31, 2024
JOHNSON MUTUAL FUNDS TRUST0.00%81,400--Mar 31, 2024
MUTUAL OF AMERICA INVESTMENT CORP0.00%92,802-7,173-7.17%Mar 31, 2024
James Alpha Funds Trust0.00%16,112--Feb 29, 2024
SSGA FUNDS0.00%948--Feb 29, 2024
Virtus Strategy Trust0.00%39,00039,000-Mar 28, 2024
Franklin Alternative Strategies Funds0.00%1,026,000--Feb 29, 2024
Principal Exchange-Traded Funds0.00%20,783-978-4.49%Mar 31, 2024
FundVantage Trust0.00%26,2665,47826.35%Mar 28, 2024
FIDELITY CONCORD STREET TRUST0.00%312,065-3,563-1.13%Feb 29, 2024
Legg Mason ETF Investment Trust0.00%2,829-1,020-26.50%Mar 31, 2024
MFS VARIABLE INSURANCE TRUST III0.00%23,272--Mar 31, 2024
USCF ETF Trust0.00%272--Mar 31, 2024
Fidelity Commonwealth Trust II0.00%8,917--Aug 31, 2023
Calvert Variable Products, Inc.0.00%3,419--Mar 31, 2024
RYDEX VARIABLE TRUST0.00%1,47035431.72%Dec 31, 2023
GABELLI EQUITY TRUST INC0.00%1,500--Dec 29, 2023
VANGUARD TAX-MANAGED FUNDS0.00%247,898-6,872-2.70%Mar 31, 2024
PRINCIPAL VARIABLE CONTRACTS FUNDS INC0.00%48,800--Mar 31, 2024
Virtus Strategy Trust0.00%25,000--Mar 28, 2024
STONE RIDGE TRUST0.00%28,515--Jan 31, 2024
TIMOTHY PLAN0.00%5,384--Mar 31, 2024
Franklin Alternative Strategies Funds0.00%635,000--Feb 29, 2024
BNY Mellon Strategic Funds, Inc.0.00%2,237-7,429-76.86%Feb 29, 2024
JANUS INVESTMENT FUND0.00%298,747-113,743-27.57%Dec 31, 2023
FIDELITY COVINGTON TRUST0.00%17,850-247-1.36%Jan 31, 2024
PRAXIS MUTUAL FUNDS0.00%9,8004,930101.23%Dec 31, 2023
SHELTON FUNDS0.00%1,483--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%895,761195,90027.99%Jan 31, 2024
ADVISORS' INNER CIRCLE FUND0.00%20,14613,708212.92%Jan 31, 2024
BMO FUNDS, INC.0.00%32,418-3,246-9.10%Nov 30, 2021
GPS Funds I0.00%4,309--Mar 31, 2024
ETF Series Solutions0.00%16,685--Jan 31, 2024

Collegium Pharmaceutical's largest mutual fund holder by % of total assets is "GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC", owning 1.00M shares, compromising 1.26% of its total assets.

Collegium Pharmaceutical Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24107-53.48%
31 Mar, 2423017.95%
31 Dec, 2319511.43%
30 Sep, 23175-4.37%
30 Jun, 23183-8.04%
31 Mar, 231999.34%
31 Dec, 2218210.98%
30 Sep, 221643.14%
30 Jun, 22159-7.02%
31 Mar, 221718.92%
31 Dec, 211572.61%
30 Sep, 21153-3.16%
30 Jun, 21158-5.39%
31 Mar, 2116716.78%
31 Dec, 201431.42%
30 Sep, 20141-8.44%
30 Jun, 20154-6.10%
31 Mar, 2016419.71%
31 Dec, 1913717.09%
30 Sep, 19117-10.00%
30 Jun, 19130-10.34%
31 Mar, 1914518.85%
31 Dec, 18122-5.43%
30 Sep, 18129-7.86%
30 Jun, 18140-3.45%
31 Mar, 1814538.10%
31 Dec, 1710538.16%
30 Sep, 17761.33%
30 Jun, 1775-14.77%
31 Mar, 1788-2.22%
31 Dec, 169023.29%
30 Sep, 1673-3.95%
30 Jun, 16767.04%
31 Mar, 167120.34%
31 Dec, 155922.92%
30 Sep, 15484.35%
30 Jun, 1546-

As of 30 Jun 24, 107 institutions are holding Collegium Pharmaceutical's shares, representing a decrease of -53.48% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2411,494,210-71.14%
31 Mar, 2439,829,3001.56%
31 Dec, 2339,219,2131.31%
30 Sep, 2338,712,156-1.75%
30 Jun, 2339,402,6301.03%
31 Mar, 2338,999,7468.12%
31 Dec, 2236,071,6110.66%
30 Sep, 2235,835,900-1.67%
30 Jun, 2236,443,4621.06%
31 Mar, 2236,061,1100.66%
31 Dec, 2135,823,657-1.73%
30 Sep, 2136,454,385-4.06%
30 Jun, 2137,998,922-0.03%
31 Mar, 2138,008,4582.20%
31 Dec, 2037,191,6950.52%
30 Sep, 2037,000,033-0.09%
30 Jun, 2037,032,5540.34%
31 Mar, 2036,907,19817.22%
31 Dec, 1931,484,4944.94%
30 Sep, 1930,002,739-2.57%
30 Jun, 1930,793,775-1.97%
31 Mar, 1931,414,166-6.97%
31 Dec, 1833,768,5620.99%
30 Sep, 1833,436,9877.62%
30 Jun, 1831,069,1012.47%
31 Mar, 1830,321,0646.48%
31 Dec, 1728,474,7189.44%
30 Sep, 1726,019,2115.99%
30 Jun, 1724,547,6735.12%
31 Mar, 1723,352,9670.20%
31 Dec, 1623,306,09446.86%
30 Sep, 1615,869,9708.52%
30 Jun, 1614,623,359-1.63%
31 Mar, 1614,864,92925.10%
31 Dec, 1511,882,799-19.17%
30 Sep, 1514,701,79858.41%
30 Jun, 159,280,856-

Collegium Pharmaceutical (COLL) has 11.49M shares outstanding as of 30 Jun 24, down -71.14% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2435.56%0.23%
31 Mar, 24123.21%0.84%
31 Dec, 23121.42%0.92%
30 Sep, 23114.72%0.89%
30 Jun, 23113.81%0.88%
31 Mar, 23113.64%0.98%
31 Dec, 22107.41%0.97%
30 Sep, 22105.22%0.92%
30 Jun, 22107.18%0.93%
31 Mar, 22107.61%1.02%
31 Dec, 21102.54%0.97%
30 Sep, 21103.05%0.89%
30 Jun, 21107.64%0.91%
31 Mar, 21108.75%0.94%
31 Dec, 20107.51%0.94%
30 Sep, 20107.12%0.92%
30 Jun, 20107.67%0.92%
31 Mar, 20108.23%1.22%
31 Dec, 1994.11%1.17%
30 Sep, 1989.61%1.05%
30 Jun, 1992.20%1.04%
31 Mar, 1994.25%0.89%
31 Dec, 18102.70%1.00%
30 Sep, 18101.29%1.14%
30 Jun, 1894.24%1.11%
31 Mar, 1892.15%1.20%
31 Dec, 1787.59%1.15%
30 Sep, 1787.45%1.26%
30 Jun, 1783.38%1.32%
31 Mar, 1779.57%1.07%
31 Dec, 1686.17%1.88%
30 Sep, 1667.65%1.73%
30 Jun, 1662.45%1.51%
31 Mar, 1664.27%0.83%
31 Dec, 1587.75%0.74%
30 Sep, 15108.56%1.75%
30 Jun, 1578.71%-

As of 30 Jun 24, Collegium Pharmaceutical is held by 35.56% institutional shareholders, representing a 0.23% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2458-54.69%
31 Mar, 2412840.66%
31 Dec, 2391-
30 Sep, 239112.35%
30 Jun, 2381-27.03%
31 Mar, 2311142.31%
31 Dec, 2278-4.88%
30 Sep, 228215.49%
30 Jun, 2271-19.32%
31 Mar, 228820.55%
31 Dec, 21732.82%
30 Sep, 2171-8.97%
30 Jun, 2178-9.30%
31 Mar, 218643.33%
31 Dec, 206011.11%
30 Sep, 2054-33.33%
30 Jun, 2081-11.96%
31 Mar, 209212.20%
31 Dec, 198246.43%
30 Sep, 1956-28.21%
30 Jun, 19781.30%
31 Mar, 197737.50%
31 Dec, 1856-16.42%
30 Sep, 1867-11.84%
30 Jun, 1876-9.52%
31 Mar, 188420.00%
31 Dec, 177094.44%
30 Sep, 1736-18.18%
30 Jun, 1744-13.73%
31 Mar, 1751-20.31%
31 Dec, 166477.78%
30 Sep, 1636-29.41%
30 Jun, 1651-10.53%
31 Mar, 165772.73%
31 Dec, 153310.00%
30 Sep, 1530-34.78%
30 Jun, 1546-

58 institutional shareholders have increased their position in COLL stock as of 30 Jun 24 compared to 128 in the previous quarter (a -54.69% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2435-55.70%
31 Mar, 24792.60%
31 Dec, 237728.33%
30 Sep, 2360-14.29%
30 Jun, 237011.11%
31 Mar, 2363-11.27%
31 Dec, 227147.92%
30 Sep, 2248-27.27%
30 Jun, 226617.86%
31 Mar, 2256-1.75%
31 Dec, 21575.56%
30 Sep, 215425.58%
30 Jun, 2143-24.56%
31 Mar, 21573.64%
31 Dec, 2055-6.78%
30 Sep, 205911.32%
30 Jun, 20533.92%
31 Mar, 205130.77%
31 Dec, 193921.88%
30 Sep, 1932-
30 Jun, 1932-25.58%
31 Mar, 1943-10.42%
31 Dec, 184841.18%
30 Sep, 1834-5.56%
30 Jun, 1836-7.69%
31 Mar, 1839178.57%
31 Dec, 1714-17.65%
30 Sep, 17176.25%
30 Jun, 1716-20.00%
31 Mar, 1720122.22%
31 Dec, 169-40.00%
30 Sep, 1615-6.25%
30 Jun, 1616100.00%
31 Mar, 168-46.67%
31 Dec, 151566.67%
30 Sep, 159-
30 Jun, 15--

35 institutional shareholders have reduced their position in COLL stock as of 30 Jun 24 compared to 79 in the previous quarter (a -55.70% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24107-53.48%11,494,210-71.14%35.56%0.23%58-54.69%35-55.70%
31 Mar, 2423017.95%39,829,3001.56%123.21%0.84%12840.66%792.60%
31 Dec, 2319511.43%39,219,2131.31%121.42%0.92%91-7728.33%
30 Sep, 23175-4.37%38,712,156-1.75%114.72%0.89%9112.35%60-14.29%
30 Jun, 23183-8.04%39,402,6301.03%113.81%0.88%81-27.03%7011.11%
31 Mar, 231999.34%38,999,7468.12%113.64%0.98%11142.31%63-11.27%
31 Dec, 2218210.98%36,071,6110.66%107.41%0.97%78-4.88%7147.92%
30 Sep, 221643.14%35,835,900-1.67%105.22%0.92%8215.49%48-27.27%
30 Jun, 22159-7.02%36,443,4621.06%107.18%0.93%71-19.32%6617.86%
31 Mar, 221718.92%36,061,1100.66%107.61%1.02%8820.55%56-1.75%
31 Dec, 211572.61%35,823,657-1.73%102.54%0.97%732.82%575.56%
30 Sep, 21153-3.16%36,454,385-4.06%103.05%0.89%71-8.97%5425.58%
30 Jun, 21158-5.39%37,998,922-0.03%107.64%0.91%78-9.30%43-24.56%
31 Mar, 2116716.78%38,008,4582.20%108.75%0.94%8643.33%573.64%
31 Dec, 201431.42%37,191,6950.52%107.51%0.94%6011.11%55-6.78%
30 Sep, 20141-8.44%37,000,033-0.09%107.12%0.92%54-33.33%5911.32%
30 Jun, 20154-6.10%37,032,5540.34%107.67%0.92%81-11.96%533.92%
31 Mar, 2016419.71%36,907,19817.22%108.23%1.22%9212.20%5130.77%
31 Dec, 1913717.09%31,484,4944.94%94.11%1.17%8246.43%3921.88%
30 Sep, 19117-10.00%30,002,739-2.57%89.61%1.05%56-28.21%32-
30 Jun, 19130-10.34%30,793,775-1.97%92.20%1.04%781.30%32-25.58%
31 Mar, 1914518.85%31,414,166-6.97%94.25%0.89%7737.50%43-10.42%
31 Dec, 18122-5.43%33,768,5620.99%102.70%1.00%56-16.42%4841.18%
30 Sep, 18129-7.86%33,436,9877.62%101.29%1.14%67-11.84%34-5.56%
30 Jun, 18140-3.45%31,069,1012.47%94.24%1.11%76-9.52%36-7.69%
31 Mar, 1814538.10%30,321,0646.48%92.15%1.20%8420.00%39178.57%
31 Dec, 1710538.16%28,474,7189.44%87.59%1.15%7094.44%14-17.65%
30 Sep, 17761.33%26,019,2115.99%87.45%1.26%36-18.18%176.25%
30 Jun, 1775-14.77%24,547,6735.12%83.38%1.32%44-13.73%16-20.00%
31 Mar, 1788-2.22%23,352,9670.20%79.57%1.07%51-20.31%20122.22%
31 Dec, 169023.29%23,306,09446.86%86.17%1.88%6477.78%9-40.00%
30 Sep, 1673-3.95%15,869,9708.52%67.65%1.73%36-29.41%15-6.25%
30 Jun, 16767.04%14,623,359-1.63%62.45%1.51%51-10.53%16100.00%
31 Mar, 167120.34%14,864,92925.10%64.27%0.83%5772.73%8-46.67%
31 Dec, 155922.92%11,882,799-19.17%87.75%0.74%3310.00%1566.67%
30 Sep, 15484.35%14,701,79858.41%108.56%1.75%30-34.78%9-
30 Jun, 1546-9,280,856-78.71%-46---

Collegium Pharmaceutical Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 05, 2024Kuhlmann Shirley R.officer EVP and General CounselS-SaleSell24,300$32.55$790.93K140,109
Jun 05, 2024Kuhlmann Shirley R.officer EVP and General CounselS-SaleSell700$33.22$23.25K139,409
May 29, 2024Tupper Colleenofficer EVP & Chief Financial OfficerS-SaleSell19,710$34.21$674.37K130,845
May 28, 2024Dreyer Scottofficer EVP & Chief Commercial OfficerS-SaleSell51,209$33.82$1.73M138,918
May 28, 2024Dreyer Scottofficer EVP & Chief Commercial OfficerS-SaleSell56,807$33.98$1.93M105,902
May 16, 2024BOHLIN GAREN Gdirector-S-SaleSell28,985$32.30$936.31K44,775

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 05, 2024Kuhlmann Shirley R.officer EVP and General CounselS-SaleSell24,300$32.55$790.93K140,109
Jun 05, 2024Kuhlmann Shirley R.officer EVP and General CounselS-SaleSell700$33.22$23.25K139,409
May 29, 2024Tupper Colleenofficer EVP & Chief Financial OfficerS-SaleSell19,710$34.21$674.37K130,845
May 28, 2024Dreyer Scottofficer EVP & Chief Commercial OfficerS-SaleSell51,209$33.82$1.73M138,918
May 28, 2024Dreyer Scottofficer EVP & Chief Commercial OfficerS-SaleSell56,807$33.98$1.93M105,902
May 28, 2024Dreyer Scottofficer EVP & Chief Commercial OfficerM-ExemptSell51,209$24.03$1.23M23,791
May 28, 2024Dreyer Scottofficer EVP & Chief Commercial OfficerM-ExemptSell23,791$24.03$571.70K-
May 16, 2024BOHLIN GAREN Gdirector-S-SaleSell28,985$32.30$936.31K44,775
May 16, 2024BOHLIN GAREN Gdirector-M-ExemptSell28,985$5.73$166.08K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 05, 2024Kuhlmann Shirley R.officer EVP and General CounselS-SaleSell24,300$32.55$790.93K140,109
Jun 05, 2024Kuhlmann Shirley R.officer EVP and General CounselS-SaleSell700$33.22$23.25K139,409
May 29, 2024Tupper Colleenofficer EVP & Chief Financial OfficerS-SaleSell19,710$34.21$674.37K130,845
May 28, 2024Dreyer Scottofficer EVP & Chief Commercial OfficerM-ExemptBuy51,209$24.03$1.23M190,127
May 28, 2024Dreyer Scottofficer EVP & Chief Commercial OfficerM-ExemptBuy23,791$24.03$571.70K162,709
May 28, 2024Dreyer Scottofficer EVP & Chief Commercial OfficerS-SaleSell51,209$33.82$1.73M138,918
May 28, 2024Dreyer Scottofficer EVP & Chief Commercial OfficerS-SaleSell56,807$33.98$1.93M105,902
May 28, 2024Dreyer Scottofficer EVP & Chief Commercial OfficerM-ExemptSell51,209$24.03$1.23M23,791
May 28, 2024Dreyer Scottofficer EVP & Chief Commercial OfficerM-ExemptSell23,791$24.03$571.70K-
May 16, 2024SANTINI GINOdirector-A-AwardBuy7,693--75,656
May 16, 2024Melincoff Gwen Adirector-A-AwardBuy7,693--52,468
May 16, 2024McFarlane Neil F.director-A-AwardBuy7,693--49,365
May 16, 2024Freund John Gordondirector-A-AwardBuy7,693--52,468
May 16, 2024Fallon John A.director-A-AwardBuy7,693--54,843
May 16, 2024Balice-Gordon Rita J.director-A-AwardBuy7,693--46,488
May 16, 2024Heffernan Michael Thomasdirector-A-AwardBuy7,693--45,508
May 16, 2024BOHLIN GAREN Gdirector-M-ExemptBuy28,985$5.73$166.08K73,760
May 16, 2024BOHLIN GAREN Gdirector-A-AwardBuy7,693--52,468
May 16, 2024BOHLIN GAREN Gdirector-S-SaleSell28,985$32.30$936.31K44,775
May 16, 2024BOHLIN GAREN Gdirector-M-ExemptSell28,985$5.73$166.08K-

The last insider sell of Collegium Pharmaceutical's stock was made by Kuhlmann Shirley R. on Jun 05 2024, selling 24,300 shares at $32.55 per share (valued at $790.93K).

Collegium Pharmaceutical Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024119122.22%
Q1 2024101471.43%
Q4 202351050.00%
Q2 202387114.29%
Q1 2023101662.50%
Q4 2022172860.71%
Q3 2022-4-
Q2 202291900.00%
Q1 2022121963.16%
Q4 2021-1-
Q3 2021-5-
Q2 202191090.00%
Q1 20213328117.86%
Q4 20201425.00%
Q3 20202922.22%
Q2 20201816112.50%
Q1 2020141687.50%
Q4 20194944.44%
Q3 201921414.29%
Q2 20191810180.00%

11 total buy trades, and 9 total sell trades (buy/sell ratio of 1.22%) were made by Collegium Pharmaceutical's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-6-
Q1 2024-4-
Q4 2023-5-
Q2 2023-7-
Q1 2023-7-
Q4 2022-16-
Q3 2022-2-
Q2 2022---
Q1 2022-3-
Q4 2021-1-
Q3 2021---
Q2 2021-4-
Q1 2021-11-
Q4 2020-2-
Q3 2020-2-
Q2 2020-11-
Q1 2020-3-
Q4 2019-4-
Q3 2019-3-
Q2 2019-8-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 6 open market sell trades of Collegium Pharmaceutical's stocks.

Collegium Pharmaceutical Peer Ownership


TickerCompany
ITCIIntra-Cellular Therapies, Inc.
RDYDr. Reddy's Laboratories Limited
ANIPANI Pharmaceuticals, Inc.
PAHCPhibro Animal Health Corporation
RGCRegencell Bioscience Holdings Limited
SSICSilver Spike Investment Corp.
PROCProcaps Group S.A.
PBHPrestige Consumer Healthcare Inc.
ALKSAlkermes plc
PCRXPacira BioSciences, Inc.
EGRXEagle Pharmaceuticals, Inc.
EOLSEvolus, Inc.
AMPHAmphastar Pharmaceuticals, Inc.

COLL Ownership FAQ


Collegium Pharmaceutical is owned by institutional shareholders (35.56%), insiders (1.38%), and public (63.06%). The largest institutional shareholder of Collegium Pharmaceutical is BLACKROCK INC. (17.92% of total shares) and the top mutual fund owner is GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC (1.26% of total shares).

Collegium Pharmaceutical's major institutional shareholders are BLACKROCK INC., PACER ADVISORS, INC., EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, and RUBRIC CAPITAL MANAGEMENT LP. The top five shareholders own together 51.17% of the company's share outstanding.

As of Jun 2024, there are 107 institutional shareholders of Collegium Pharmaceutical.

BLACKROCK INC owns 5.79M shares of Collegium Pharmaceutical, representing 17.92% of the company's total shares outstanding, valued at $186.55M (as of Jun 2024).

As of Jun 2024, PACER ADVISORS, INC holds 3.41M shares of Collegium Pharmaceutical (COLL), compromising 10.54% of the company, valued at $109.75M.

EVENTIDE ASSET MANAGEMENT, LLC is the third largest holder of Collegium Pharmaceutical. The company owns 2.63M of the company's shares outstanding (worth $84.84M).